IBDEI059 ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,2168,0)
 ;;=788.41^^21^188^17
 ;;^UTILITY(U,$J,358.3,2168,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2168,1,4,0)
 ;;=4^788.41
 ;;^UTILITY(U,$J,358.3,2168,1,5,0)
 ;;=5^Urinary Frequency
 ;;^UTILITY(U,$J,358.3,2168,2)
 ;;=^124396
 ;;^UTILITY(U,$J,358.3,2169,0)
 ;;=788.20^^21^188^19
 ;;^UTILITY(U,$J,358.3,2169,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2169,1,4,0)
 ;;=4^788.20
 ;;^UTILITY(U,$J,358.3,2169,1,5,0)
 ;;=5^Urinary Retention
 ;;^UTILITY(U,$J,358.3,2169,2)
 ;;=^295812
 ;;^UTILITY(U,$J,358.3,2170,0)
 ;;=600.01^^21^188^1
 ;;^UTILITY(U,$J,358.3,2170,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2170,1,4,0)
 ;;=4^600.01
 ;;^UTILITY(U,$J,358.3,2170,1,5,0)
 ;;=5^BPH w/ Obstruction
 ;;^UTILITY(U,$J,358.3,2170,2)
 ;;=^329933
 ;;^UTILITY(U,$J,358.3,2171,0)
 ;;=600.00^^21^188^2
 ;;^UTILITY(U,$J,358.3,2171,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2171,1,4,0)
 ;;=4^600.00
 ;;^UTILITY(U,$J,358.3,2171,1,5,0)
 ;;=5^BPH w/o Obstruction
 ;;^UTILITY(U,$J,358.3,2171,2)
 ;;=^334276
 ;;^UTILITY(U,$J,358.3,2172,0)
 ;;=595.9^^21^188^4
 ;;^UTILITY(U,$J,358.3,2172,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2172,1,4,0)
 ;;=4^595.9
 ;;^UTILITY(U,$J,358.3,2172,1,5,0)
 ;;=5^Cystitis
 ;;^UTILITY(U,$J,358.3,2172,2)
 ;;=^30304
 ;;^UTILITY(U,$J,358.3,2173,0)
 ;;=585.6^^21^188^6
 ;;^UTILITY(U,$J,358.3,2173,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2173,1,4,0)
 ;;=4^585.6
 ;;^UTILITY(U,$J,358.3,2173,1,5,0)
 ;;=5^End Stage Renal Disease
 ;;^UTILITY(U,$J,358.3,2173,2)
 ;;=^303986
 ;;^UTILITY(U,$J,358.3,2174,0)
 ;;=592.0^^21^188^8
 ;;^UTILITY(U,$J,358.3,2174,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2174,1,4,0)
 ;;=4^592.0
 ;;^UTILITY(U,$J,358.3,2174,1,5,0)
 ;;=5^Kidney Stone
 ;;^UTILITY(U,$J,358.3,2174,2)
 ;;=^67056
 ;;^UTILITY(U,$J,358.3,2175,0)
 ;;=590.01^^21^188^15
 ;;^UTILITY(U,$J,358.3,2175,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2175,1,4,0)
 ;;=4^590.01
 ;;^UTILITY(U,$J,358.3,2175,1,5,0)
 ;;=5^Pyelonephritis,Chr w/ Med Nec
 ;;^UTILITY(U,$J,358.3,2175,2)
 ;;=^270368
 ;;^UTILITY(U,$J,358.3,2176,0)
 ;;=584.9^^21^188^16
 ;;^UTILITY(U,$J,358.3,2176,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2176,1,4,0)
 ;;=4^584.9
 ;;^UTILITY(U,$J,358.3,2176,1,5,0)
 ;;=5^Renal Failure,Acute
 ;;^UTILITY(U,$J,358.3,2176,2)
 ;;=^338532
 ;;^UTILITY(U,$J,358.3,2177,0)
 ;;=233.7^^21^189^12
 ;;^UTILITY(U,$J,358.3,2177,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2177,1,4,0)
 ;;=4^233.7
 ;;^UTILITY(U,$J,358.3,2177,1,5,0)
 ;;=5^Ca In-Situ Bladder
 ;;^UTILITY(U,$J,358.3,2177,2)
 ;;=^267742
 ;;^UTILITY(U,$J,358.3,2178,0)
 ;;=233.0^^21^189^13
 ;;^UTILITY(U,$J,358.3,2178,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2178,1,4,0)
 ;;=4^233.0
 ;;^UTILITY(U,$J,358.3,2178,1,5,0)
 ;;=5^Ca In-Situ Breast
 ;;^UTILITY(U,$J,358.3,2178,2)
 ;;=Ca In-Situ Breast^267735
 ;;^UTILITY(U,$J,358.3,2179,0)
 ;;=233.1^^21^189^14
 ;;^UTILITY(U,$J,358.3,2179,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2179,1,4,0)
 ;;=4^233.1
 ;;^UTILITY(U,$J,358.3,2179,1,5,0)
 ;;=5^Ca In-Situ Cervix
 ;;^UTILITY(U,$J,358.3,2179,2)
 ;;=^267736
 ;;^UTILITY(U,$J,358.3,2180,0)
 ;;=232.9^^21^189^15
 ;;^UTILITY(U,$J,358.3,2180,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2180,1,4,0)
 ;;=4^232.9
 ;;^UTILITY(U,$J,358.3,2180,1,5,0)
 ;;=5^Ca In-Situ Skin
 ;;^UTILITY(U,$J,358.3,2180,2)
 ;;=^267724
 ;;^UTILITY(U,$J,358.3,2181,0)
 ;;=156.2^^21^189^2
 ;;^UTILITY(U,$J,358.3,2181,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2181,1,4,0)
 ;;=4^156.2
 ;;^UTILITY(U,$J,358.3,2181,1,5,0)
 ;;=5^Ca Ampulla Of Vater
 ;;^UTILITY(U,$J,358.3,2181,2)
 ;;=^267100
 ;;^UTILITY(U,$J,358.3,2182,0)
 ;;=154.3^^21^189^3
